INS and metabolic dysfunction-associated steatohepatitis: Indeed, a growing body of evidence indicates that the primary defect in NASH subjects occurs in adipose tissue 14, from which triglyceride-derived toxic metabolites including the NEFA pool, impair insulin signalling in both skeletal muscle and liver tissue (‘lipotoxicity’).